의료용 온도 모니터링 기기 시장 : 기기 유형별, 측정 모드별, 용도별 - 세계 예측(2026-2032년)

The Healthcare Temperature Monitoring Devices Market was valued at USD 6.01 billion in 2025 and is projected to grow to USD 6.34 billion in 2026, with a CAGR of 6.11%, reaching USD 9.11 billion by 2032.

How clinical priorities, digital transformation, and patient-centric expectations are reshaping temperature monitoring requirements across modern care pathways

Healthcare systems and device manufacturers face escalating expectations for accurate, continuous, and context-aware temperature monitoring across diverse care environments. Clinicians increasingly demand solutions that integrate seamlessly with electronic health records, support remote monitoring workflows, and minimize patient disturbance. As a result, technology suppliers are converging sensor accuracy, miniaturization, and connectivity into cohesive offerings that prioritize usability and clinical relevance.

Moreover, the broader shift to value-based care has raised the operational stakes for temperature monitoring. Temperature trends now influence sepsis screening, infection control protocols, and post-operative surveillance, which amplifies the importance of reliable devices and robust data capture. At the same time, consumers have grown more comfortable with wearables and home-based monitoring tools, prompting healthcare providers to reconsider monitoring paradigms that extend beyond the hospital bed. Consequently, stakeholder expectations now include not only device performance but also data integrity, cybersecurity, and longitudinal analytics.

Transitioning from point measurements to clinically actionable streams requires harmonized standards, workflow integration, and clear evidence of clinical utility. As this introduction underscores, temperature monitoring technology sits at the intersection of clinical need and digital transformation, creating opportunities for innovation while demanding rigorous validation and implementation planning.

Technological maturation, regulatory emphasis, interoperability demands, and supply-chain resilience are collectively accelerating the evolution of temperature monitoring solutions

The landscape for temperature monitoring devices is undergoing transformative shifts driven by several converging forces. First, sensor technology has matured to enable higher accuracy in smaller form factors, facilitating the development of wearable patches and smartwatches that can deliver near-continuous temperature data with minimal patient burden. This evolution expands monitoring beyond acute settings and supports longitudinal health insights that were previously impractical.

Second, connectivity and data platforms are redefining how temperature data is consumed. Integration with hospital information systems and remote patient monitoring platforms allows temperature streams to trigger automated alerts, feed risk stratification models, and support telehealth consultations. Consequently, temperature monitoring is no longer an isolated measurement but a component of broader digital health ecosystems that prioritize interoperability and scalable analytics.

Third, regulatory expectations and reimbursement models are evolving in response to evidence of clinical benefit. Regulators now demand clearer demonstrations of measurement accuracy, data security, and user safety, while payers increasingly evaluate devices for their ability to reduce avoidable admissions and support care transitions. These shifts incentivize vendors to invest in clinical validation, human factors engineering, and post-market surveillance.

Finally, supply-chain resilience and manufacturing agility have emerged as critical competitive differentiators. Firms that can rapidly scale production, localize manufacturing, and navigate tariff and trade environments gain strategic advantage. Taken together, these transformative shifts are accelerating the maturation of temperature monitoring solutions and reshaping the competitive and operational calculus for stakeholders across the ecosystem.

Shifts in 2025 tariff regimes are prompting supply-chain diversification, nearshoring considerations, and strategic procurement adaptations across the temperature monitoring value chain

United States tariff policy developments in 2025 have introduced new variables that reverberate through procurement strategies, sourcing decisions, and manufacturing footprints for temperature monitoring devices. Tariffs that affect components or finished devices prompt device OEMs and contract manufacturers to reassess supplier relationships, cost structures, and inventory strategies. In response, organizations are increasingly exploring regional diversification of supply chains and selective reshoring to mitigate exposure to tariff volatility.

Consequently, procurement teams are adapting contractual terms to include greater flexibility for alternative sourcing and to incorporate tariff pass-through considerations. This adaptability reduces near-term disruption but also adds complexity to supplier management and forecasting. At the same time, manufacturers are evaluating component substitution strategies and qualification pathways to preserve product performance while navigating new cost inputs. These activities often require additional validation work and regulatory re-submissions, which can extend time-to-market if not proactively managed.

Additionally, tariff-induced cost pressures are accelerating conversations about nearshoring and strategic inventory buffers. Stakeholders are engaging in scenario planning to understand the operational implications of sustained trade frictions, including potential adjustments to pricing strategies, channel incentives, and localized service models. Importantly, organizations that prioritize transparent supplier relationships and invest in flexible manufacturing capacity position themselves to respond more nimbly to tariff fluctuations and to maintain supply continuity for clinical customers.

A multi-dimensional segmentation analysis linking device architecture, monitoring mode, and care setting nuances to inform differentiated product and go-to-market decisions

A nuanced segmentation framework clarifies how device types, monitoring modes, and clinical applications shape product design, adoption patterns, and value propositions. Based on device type, product strategies diverge across fixed units, portable instruments, and wearable devices. Fixed solutions emphasize robust integration and sensor durability and commonly utilize infrared sensor technology or thermistor probe configurations to serve continuous monitoring needs in defined care environments. Portable instruments prioritize rapid measurements and user mobility, with handheld thermometers and thermal scanners offering quick assessments for triage and screening workflows. Wearable solutions target longitudinal monitoring and patient comfort, taking the form of adhesive patches or smartwatch platforms that enable extended observation outside traditional settings.

Based on monitoring mode, clinical use cases separate into continuous and intermittent modalities, each with distinct workflow and data management implications. Continuous monitoring supports early-warning systems and automated alerts but requires attention to data fidelity, alarm fatigue, and integration with clinician workflows. Intermittent monitoring aligns with periodic assessments and is often preferred in lower-acuity settings or where continuous telemetry is unnecessary.

Based on application, device requirements and procurement priorities differ across general ward, home healthcare, and intensive care unit environments. General wards favor solutions that balance accuracy with ease of use and minimal interruption to routine nursing care. Home healthcare demands devices with patient-friendly interfaces, reliable remote connectivity, and battery longevity. Intensive care unit deployments prioritize the highest-accuracy sensors and validated integration with advanced monitoring platforms, and within that context the needs of adult ICU and pediatric ICU populations diverge in terms of sensor placement, form factor, and clinical thresholds. These segmentation lenses guide product development, clinical validation plans, and commercialization strategies by aligning technical capabilities with distinct use-case requirements.

Regional regulatory heterogeneity, procurement structures, and digital health maturity establish differentiated adoption pathways and commercialization priorities across global markets

Regional dynamics exert a powerful influence on adoption pathways, regulatory navigation, and commercialization approaches for temperature monitoring devices. In the Americas, healthcare systems display a mix of centralized procurement and decentralized purchasing at health system levels, which shapes vendor engagement strategies and reimbursement conversations. This region also demonstrates a strong appetite for solutions that integrate with large electronic health record platforms and that support complex hospital workflows, prompting vendors to prioritize interoperability and local clinical evidence generation.

In Europe, the Middle East & Africa, regulatory frameworks and procurement mechanisms vary substantially, requiring adaptive regulatory strategies and flexible pricing models. Reimbursement and procurement processes in parts of this region emphasize cost-effectiveness and long-term operational impact, which increases the importance of health economics studies and partnerships with regional distributors to navigate fragmented markets.

In the Asia-Pacific region, rapid adoption of digital health platforms and a diverse mix of public and private healthcare providers create both high opportunity and complexity. Stakeholders here often balance aggressive digital transformation initiatives with a need for localized clinical validation and supply-chain responsiveness. Across all regions, localized support, tailored clinical evidence, and compliance with regional privacy and medical device regulations are essential for sustained adoption. Understanding these regional contours enables more effective allocation of commercial resources and targeted clinical engagement strategies.

Competitive advantage emerges from integrated sensor innovation, clinical validation partnerships, resilient manufacturing, and service-oriented commercialization strategies

Competitive dynamics in the temperature monitoring landscape emphasize rapid product iteration, strategic partnerships, and clarity around clinical differentiation. Leading device developers are investing in sensor accuracy, miniaturization, and low-power connectivity while simultaneously accelerating clinical validation programs to substantiate claims. Partnerships between medical device firms and digital health platforms have become increasingly common, enabling richer analytics, centralized device management, and improved clinician workflows.

In addition to product innovation, go-to-market strategies that prioritize channel relationships and service models are gaining prominence. Organizations that combine compelling device performance with dependable logistics, localized technical support, and clear training pathways foster stronger trust among clinical customers. Moreover, strategic collaborations with academic centers and health systems help validate device efficacy in real-world settings and generate the clinical evidence necessary for guideline adoption.

From an operational perspective, companies that demonstrate manufacturing agility and transparent supply-chain practices stand out. Investors and health system buyers increasingly scrutinize not only product specifications but also continuity-of-supply plans and quality systems. Consequently, companies that balance technical innovation with robust commercialization and operational execution are best positioned to scale adoption across care settings.

Practical steps for device makers and health systems to align clinical evidence, interoperability, supply resilience, and service delivery to accelerate adoption and trust

Industry leaders should prioritize a set of pragmatic actions to capture clinical trust and commercial traction in temperature monitoring. First, invest in targeted clinical validation that aligns device performance with specific workflows and outcomes, ensuring evidence packages speak directly to clinician concerns and payer requirements. This evidence should address accuracy across physiologic ranges, performance under real-world conditions, and impact on clinical decision-making.

Second, design for interoperability from the outset. Implement open integration standards and provide robust APIs so devices can feed into electronic health records, remote monitoring platforms, and hospital alarm systems. This reduces friction at the point of deployment and accelerates adoption across integrated care environments. Third, build flexible supply-chain strategies that incorporate alternative sourcing, localized manufacturing options, and inventory buffers to manage tariff and trade risks. Such resilience reduces operational disruption and supports reliable customer commitments.

Fourth, differentiate through service and support: complementary offerings such as training programs, implementation playbooks, and analytics dashboards increase the realized value of devices and strengthen long-term relationships. Finally, engage with regulators and payers early to align clinical evidence generation with approval pathways and reimbursement criteria. By executing these actions in concert, industry leaders will better align product capabilities with clinical needs and organizational procurement priorities.

A robust mixed-methods research framework integrating clinical literature, regulatory review, stakeholder interviews, and operational scenario analysis to support implementation-focused insights

The research approach combined a systematic review of peer-reviewed clinical literature, regulatory filings, and device technical specifications with stakeholder interviews across clinical, procurement, and manufacturing domains. Primary qualitative interviews included clinicians from hospital and home-health settings, device engineers, and supply-chain professionals to surface practical challenges and opportunities related to device usability, validation requirements, and production constraints. These insights were triangulated with analysis of regulatory guidance documents and post-market safety communications to ground recommendations in current compliance expectations.

Analytical techniques emphasized comparative device feature mapping, workflow alignment assessments, and scenario planning exercises to evaluate the operational implications of tariffs, supply-chain disruptions, and deployment models. Where applicable, human factors considerations were evaluated through task analyses and reported usability findings to assess the likelihood of adoption in high-volume clinical environments. Throughout the research, emphasis remained on evidence that informs implementation decisions rather than speculative forecasting, ensuring the outputs are directly actionable for product development, procurement, and clinical adoption stakeholders.

Synthesizing technological capability, clinical validation, and operational readiness to realize the full potential of temperature monitoring across care continuums

Temperature monitoring devices occupy a pivotal role in both acute and ambulatory care pathways, and their evolution will continue to be shaped by sensor innovation, digital integration, and operational resilience. The transition toward continuous, context-aware monitoring is enabling earlier detection of clinical deterioration and supporting remote care models, but this progress depends on rigorous validation, thoughtful workflow integration, and transparent supply-chain practices.

Organizations that align product development with explicit clinical use cases, invest in interoperability, and build resilient manufacturing strategies will be better equipped to meet clinician expectations and navigate regulatory complexities. Moreover, service-oriented commercialization that includes training, analytics, and implementation support amplifies device value in real-world settings and reduces barriers to sustained adoption. In sum, the convergence of technology and clinical workflows presents significant opportunity-but realizing that value requires disciplined evidence generation, collaborative partnerships, and operational foresight.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Healthcare Temperature Monitoring Devices Market, by Device Type

• 8.1. Fixed
  • 8.1.1. Infrared Sensor
  • 8.1.2. Thermistor Probe
• 8.2. Portable
  • 8.2.1. Handheld Thermometer
  • 8.2.2. Thermal Scanner
• 8.3. Wearable
  • 8.3.1. Patch
  • 8.3.2. Smart Watch

9. Healthcare Temperature Monitoring Devices Market, by Monitoring Mode

• 9.1. Continuous
• 9.2. Intermittent

10. Healthcare Temperature Monitoring Devices Market, by Application

• 10.1. General Ward
• 10.2. Home Healthcare
• 10.3. Intensive Care Unit
  • 10.3.1. Adult ICU
  • 10.3.2. Pediatric ICU

11. Healthcare Temperature Monitoring Devices Market, by Region

• 11.1. Americas
  • 11.1.1. North America
  • 11.1.2. Latin America
• 11.2. Europe, Middle East & Africa
  • 11.2.1. Europe
  • 11.2.2. Middle East
  • 11.2.3. Africa
• 11.3. Asia-Pacific

12. Healthcare Temperature Monitoring Devices Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Healthcare Temperature Monitoring Devices Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. United States Healthcare Temperature Monitoring Devices Market

15. China Healthcare Temperature Monitoring Devices Market

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025
• 16.5. 3M Company
• 16.6. American Diagnostic Corporation
• 16.7. Becton, Dickinson and Company
• 16.8. Braun GmbH
• 16.9. Briggs Healthcare
• 16.10. Cadi Scientific
• 16.11. Cardinal Health, Inc.
• 16.12. Dragerwerk AG & Co. KGaA
• 16.13. EarlySense Ltd.
• 16.14. Exergen Corporation
• 16.15. GE Healthcare
• 16.16. Gentherm Incorporated
• 16.17. Hicks Thermometers India Limited
• 16.18. Hill-Rom Holdings, Inc.
• 16.19. Kaz USA, Inc.
• 16.20. Koninklijke Philips N.V.
• 16.21. Masimo Corporation
• 16.22. Medtronic plc
• 16.23. Microlife Corporation
• 16.24. Omron Healthcare, Inc.
• 16.25. Sensitech, Inc.
• 16.26. Stryker Corporation
• 16.27. Terumo Corporation